Endoscopy Operative Devices Market

The market for Endoscopy Operative Devices was estimated at $12.5 billion in 2025; it is anticipated to increase to $16.6 billion by 2030, with projections indicating growth to around $22.0 billion by 2035.

Report ID:DS1801060

Author:Debadatta Patel - Senior Consultant

Published Date:January 2025

Datatree

Life Science

Medical Device

Endoscopy Operative Devices

Customization Available

Endoscopy Operative Devices - 2025-2035

Market Outlook
Market Key Insights
Growth Opportunity
Market Dynamics
Application
Recent Development
Impact Analysis

Report Summary

Market Data

Methodology

Table of Contents

Report Summary

Market Data

Methodology

Table of Contents

Global Endoscopy Operative Devices Market Outlook

Revenue, 2025

$12.5B

Forecast, 2035

$22.0B

CAGR, 2026 - 2035

5.8%

The Endoscopy Operative Devices industry revenue is expected to be around $13.2 billion in 2026 and expected to showcase growth with 5.8% CAGR between 2026 and 2035. The increasing significance of endoscopy operative equipment in healthcare is reflected in this trend, driven by growing use of minimally invasive surgical techniques, an expansion of screening procedures and the increasing number of people with conditions of the gullet and genital tract. The majority of endoscope procedure units are used in procedures for the female reproductive system and digestive tract. These two segments account for sixty five point seven% of the market for operative endoscope equipment. Reusable products generate $10.22 billion in revenue each year. This figure is largely due to their cost effectiveness and sustainability, factors which also enable these products to be compatible with advanced reprocessing technologies. Advances in ergonomics, energy and imaging technologies combined with a favourable payment environment and strong usage in both developed and emerging economies mean that the future for Endoscopy Operative Devices looks very positive. They are crucial to reducing costs and raising standards in operating theatres. The range of endoscopes and accessories available for purchase as Endoscopy Operative Devices includes flexible and rigid endoscopes, 4K and HD imaging systems and devices for hemostasis and insufflation.

Endoscopy operative devices also include equipment such as electrosurgical instruments and retrieval systems. There are also various other pieces of equipment available such as flexible endoscopes, rigid endoscopes, high definition imaging systems, electrosurgical instruments, insufflators and retrieval systems. In endoscopy, gynecologic laparoscopy, arthroscopy, pulmonology, ENT and urology, these systems are important. The technologies possess features like enhanced safety, better image resolution, and increased usability. They are compatible with digital healthcare platforms which include data integration tools. Growing demand is driven by an increase in the usage of single use endoscopes which reduce the risk of infection, the application of AI in diagnostic imaging to enhance colonoscopy diagnosis rates and other similar procedures, and also an increase in outpatients who undergo surgical operations in outpatients units.

Endoscopy Operative Devices market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2025-2035 — Endoscopy Operative Devices Market Outlook

Market Key Insights

The Endoscopy Operative Devices market is projected to grow from $12.5 billion in 2025 to $22.0 billion in 2035. This represents a CAGR of 5.8%, reflecting rising demand across Gastrointestinal procedures, Laparoscopic surgeries, and Urologic examinations.
The leading companies in the market include Medtronic, CONMED Corporation and Cook. These companies are influential in determining the competitive landscape.
The United States and Germany are expected to dominate the global endoscopy operative devices market. Their combined growth rate between 2025 and 2030 is expected to range from 3.8% to 5.6%.
The fastest development is anticipated to take place in emerging markets China, Australia and India with compound annual growth rates between 6.7% and 8%.
The trend towards minimally invasive surgery will have a greater impact on the United States and German markets in the value chain, and is predicted to increase industry revenue for endoscopic surgical devices by $343 million by 2030.
Over the decade to 2035, the operative endoscopes industry is predicted to increase in value by $9.5 billion. In this time the urology and orthopaedic application devices sector will grow at a faster rate than any other and capture an increasingly large share of the market.
Advances in technology and the growing requirement for minimally invasive surgical procedures will spur the endoscopy operative devices industry to rise by 76% between 2025 and 2035.

Endoscopy Operative Devices - Country Share Analysis

Opportunities in the Endoscopy Operative Devices

The trend towards greater infection control measures being implemented is also driving many office based endoscopy and surgical centres to use disposable items. These are single use forceps and snares and cutting equipment. The disposable endoscope equipment market currently generates a turnover of $2.3 billion. By 2030, this revenue is expected to increase to $4 billion. The rate of growth for this market is predicted to be 11.6% per annum. The major advantage is experienced in the region of high volume gastrointestinal and respiratory procedures in the US and Western Europe. This is where reprocessing of equipment is hampered by shortages of staff and changes in reimbursement.

Growth Opportunities in North America and Asia-Pacific

Use in North America is predominantly in the region of Gastrointestinal endoscopic appliances due to fully developed screening techniques for colorectal cancer, the high number of bariatric and endoscopic treatments, and the ongoing trend toward minimal invasion in surgery at hospitals and ambulatory surgical centres. High levels of competition exist in this sector with the presence of global original equipment manufacturers as well as local manufacturers specialising in the production of visualisation and energy equipment. They compete in several region's such as image quality, user comfort and how procedures are performed. Mid tier manufacturers on the other hand provide laparoscopic instruments at a lower price for general use and urology procedures. The company will be focusing on two main business region's, which are the gastro and urology platforms. These platforms combine infection control features with tools and endoscopes. Also important to the company are high volume outpatient endoscopes. Key drivers of regional growth include an ageing population, rising demand for endoscopic and arthroscopic procedures, more stringent sterilisation procedures and hospital mergers.

Asia Pacific is where endoscopy operative devices have the highest use and future demand, mainly in procedures of the digestive system. In that region however there is also increasing use in gynaecology and urology as governments set up more healthcare programmes for women and also for people suffering from urological diseases, and private medical establishments are creating new facilities for surgery which is minimally invasive. In the market, a combination of domestic companies offering low cost products and foreign companies selling high end products is present. As a result domestic companies are gaining market share in the lower end of the market for laparoscopic equipment and surgical sets. High end video equipment and complex surgical devices are however dominated by international firms. Companies in this sector have opportunities to enter markets by offering specific portfolios of gynaecology and gastro intestinal equipment and systems in certain regions. This could involve supplying hospitals with a range of equipment which can handle a high volume of patients, secondary care hospitals with systems which can be adapted to their needs and training facilities with bundles which include equipment, training and support services. Rising disposable income, rapid hospital infrastructure development and expanding health insurance coverage in India, China and Southeast Asia are major drivers in this region. Demand for flexible endoscopes and arthroscopy equipment that can allow patients to be treated in day care units and speed up recovery time by reducing hospital stays is also a significant factor.

Market Dynamics and Supply Chain

Driver: Rising Prevalence of Gastrointestinal Disorders and Surge in Minimally Invasive Surgeries Drives Device Demand

The endoscopy operative devices market is also strongly driven by the increasing prevalence of gastrointestinal disorders, including colorectal cancer, ulcers, and inflammatory bowel diseases, which necessitate frequent diagnostic and therapeutic endoscopic procedures. Aging populations, lifestyle changes, and improved screening awareness contribute to growing case numbers, expanding the need for high‑performance endoscopes, biopsy forceps, and resection tools. Simultaneously, there is also a significant shift toward minimally invasive surgeries across specialties such as general surgery, gynecology, and urology. Laparoscopic and therapeutic endoscopy procedures reduce patient trauma, shorten hospital stays, and lower complication rates compared with open surgeries. These clinical benefits have also encouraged hospitals and outpatient surgical centers to adopt advanced operative endoscopy systems equipped with high‑resolution imaging, superior maneuverability, and versatile therapeutic channels. Leading players like Olympus, Medtronic, and Fujifilm are also investing in expanded portfolios that support both diagnostic and interventional demands, reinforcing overall market growth by catering to broader procedural applications.

Technological innovation is also a key driver in the endoscopy operative devices market, particularly the development of high‑definition imaging systems, enhanced light sources, and integrated therapeutic modules. These advancements improve visualization of mucosal surfaces, enable real‑time tissue characterization, and support precise therapeutic interventions such as polyp removal, laser lithotripsy, or laparoscopic dissection. Enhanced imaging technologies like narrow band imaging and 3D visualization increase diagnostic accuracy and procedural confidence. As manufacturers continue to incorporate advanced optics, digital enhancements, and multifunctional tool compatibility, adoption rises among clinicians seeking improved outcomes and operational efficiencies.

Restraint: High Procedure Costs and Limited Reimbursement Reduce Endoscopy Utilization in Emerging Markets

The cost of endoscopy operative devices and associated procedures remains a key restraint, particularly in emerging economies where healthcare budgets are tight. Advanced endoscopes, insufflators, and electrosurgical instruments require significant investment, and limited insurance reimbursement for certain gastrointestinal and laparoscopic interventions discourages widespread adoption. For example, hospitals may defer upgrading to high‑definition systems, opting for basic equipment that limits procedural capabilities and suppresses revenue growth for premium device manufacturers.

Opportunity: AI-enabled gastrointestinal endoscopy operative devices addressing early-cancer screening needs in aging Japanese and European populations and Expansion of robotic-assisted minimally invasive surgery boosting reusable endoscopy operative devices demand across Asian hospitals

The ageing Japanese and Western European populations are increasing the need for routine screening of the gastro intestinal tract, but those skilled in endoscopic techniques are in short supply. Investment is presently being made in the AI assisted endoscopy operating platforms, as the field is missing a computer vision based tool that automates the tasks of polyp detection, characterizing lesions and the documentation of workflows. Reusable endoscopes with high definition images, along with corresponding surgical instruments which can be fed through the endoscope, that use AI computing in the cloud will grow most strongly. These will be used with disposable biopsy instruments in screenings that are high risk. Systems which are interoperable, have strong data security compliance and also offer local language clinical decision support tools will capture market share from systems that are legacy and purely optical in nature.

The rapid development of facilities in China, India and Southeast Asia is accelerating a rise in the use of laparoscopic procedures which are minimally invasive and require a high degree of skill to perform. Reusable devices in the sector generated $10.22 billion by 2025 and are expected to reach $12.61 billion by 2030 at a rate of 4.3% CAGR. The medical specialties where growth is expected to be at its highest are in complex general surgery and urology. Hospitals want instruments that can be used for a variety of procedures, ergonomic handpieces, and devices that use energy in order to be compatible with either an imaging module or a robotic system.

Challenge: Stringent Regulatory Requirements and Sterilization Challenges Delay Product Launches

Endoscopy operative devices face stringent regulatory pathways and complex sterilization standards that slow product approvals and market entry. Regulatory agencies require extensive clinical validation for safety and reprocessing efficacy, increasing development costs and prolonging time to clearance. Additionally, reusable endoscopes demand rigorous sterilization protocols to prevent infection outbreaks, driving demand for single‑use alternatives but also raising operational costs. These compliance complexities can delay innovation uptake and affect demand dynamics across healthcare facilities.

Supply Chain Landscape

Laparoscopic Instruments

Karl StorzOlympus CorporationFujifilm Healthcare

Endoscopy Operative Devices

MedtronicBoston Scientific CorporationStryker

Medical Device Distribution

Cardinal HealthOwens & MinorMedline Industries

Minimally Invasive Surgery

HospitalsAmbulatory Surgical CentersGastrointestinal Endoscopy Clinics

Laparoscopic Instruments

Karl StorzOlympus CorporationFujifilm Healthcare

Endoscopy Operative Devices

MedtronicBoston Scientific CorporationStryker

Medical Device Distribution

Cardinal HealthOwens & MinorMedline Industries

Minimally Invasive Surgery

HospitalsAmbulatory Surgical CentersGastrointestinal Endoscopy Clinics

Endoscopy Operative Devices - Supply Chain

Use Cases of Endoscopy Operative Devices in Gastrointestinal procedures & Urologic examinations

Gastrointestinal procedures : In gastrointestinal procedures, endoscopy operative devices such as gastroscopes, colonoscopes, and therapeutic endoscopes are essential for diagnosing and treating conditions including ulcers, polyps, and tumors. Advanced tools like endoscopic submucosal dissection knives, snares, and biopsy forceps enable precision tissue removal and polyp resection, improving clinical outcomes and reducing the need for open surgery. Leading players such as Olympus Corporation, Fujifilm Holdings, and Boston Scientific dominate this segment with high‑resolution imaging, ergonomic designs, and integrated therapeutic capabilities that enhance procedural accuracy and patient care in hospitals and outpatient endoscopy centers.

Laparoscopic surgeries : In laparoscopic surgeries, operative endoscopy devices such as laparoscopes, insufflators, trocars, and advanced energy instruments are widely used to perform minimally invasive procedures across general surgery, gynecology, and bariatrics. These devices provide surgeons with real‑time visualization, precise dissection, and controlled tissue manipulation, reducing postoperative pain and recovery time compared with open procedures. Major companies including Medtronic, Ethicon (Johnson & Johnson), and Karl Storz lead with integrated solutions that combine superior optics, intuitive controls, and compatible accessories, strengthening their positions in global surgical suites and ambulatory surgical centers.

Urologic examinations : For urologic examinations and interventions such as cystoscopy and ureteroscopy, operative endoscopy devices like rigid and flexible cystoscopes, ureteroscopes, and stone retrieval tools provide critical access to the urinary tract to diagnose and manage stones, strictures, and tumors. These instruments offer high‑resolution visualization and therapeutic channels for biopsy and laser lithotripsy. Top market players such as Richard Wolf GmbH, Olympus Corporation, and Stryker Corporation deliver advanced urology endoscopes with ergonomic designs and durable performance, enhancing procedure efficiency and patient comfort in urology clinics and surgical departments.

Recent Developments

The endoscopy operative devices market is advancing with strategic emphasis on AI‑enhanced imaging, 3D visualization, and robotic‑assisted endoscopic systems that improve diagnostic accuracy and procedural precision. A key market trend is the integration of digital health features such as real‑time tissue characterization and remote procedure support, which enhance clinician confidence and reduce procedure time. These innovations are increasing adoption across gastrointestinal, laparoscopic, and urologic surgery segments and driving competitive technology investments by major device manufacturers.

October 2025 : FUJIFILM Healthcare Americas Corporation announced the launch of its ELUXEO 8000 Endoscopic Imaging System with advanced LED multi‑light and enhanced imaging features at ACG 2025, confirming a significant product development

September 2025 : Olympus officially commercialized its OLYSENSE CAD/AI portfolio, introducing AI‑powered lesion detection software for endoscopy in key markets.

December 2023 : Medtronic confirmed an expanded global collaboration with Cosmo Intelligent Medical Devices to advance the GI Genius™ intelligent endoscopy module using AI technologies.

Impact of Industry Transitions on the Endoscopy Operative Devices Market

As a core segment of the Medical Device industry, the Endoscopy Operative Devices market develops in line with broader industry shifts. Over recent years, transitions such as Transition Towards Minimally Invasive Surgeries and Technological Advancements in Endoscopy Devices have redefined priorities across the Medical Device sector, influencing how the Endoscopy Operative Devices market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

Transition Towards Minimally Invasive Surgeries

The trend towards keyhole surgery is altering the market for endoscopic surgical equipment. By 2030, this trend could result in an extra $343 million revenue in the medical equipment market in Germany and the United States. With the fact that minimally invasive surgical methods carry a lower risk of complications along with reduced pain and recovery time over traditional open surgery, more healthcare providers are turning to endoscopic technology. This shift in demand is triggering a shift in purchasing priorities toward these products. The move is pushing hospitals to combine the various tools and services they use in their procedures, to get the most from them. It benefits companies that are able to supply a full range of equipment, imaging technology and maintenance agreements. In particular, hospitals are placing greater emphasis on quicker throughput, lower costs and more efficient use of operating room facilities. This is resulting in greater opportunities for companies making operative endoscopes.

Technological Advancements in Endoscopy Devices

The endoscopy operative devices industry is experiencing significant transformation due to technological advancements, including 3D imaging, high-definition optics, and AI-assisted robotic systems. These innovations enhance visualization, precision, and maneuverability during gastrointestinal, laparoscopic, and urologic procedures, enabling minimally invasive surgeries with improved patient outcomes and reduced operative times. The transition is also influencing surgical robotics, hospital infrastructure, and medical device manufacturing, as facilities adopt hybrid operating rooms and integrated imaging systems. For example, robotic-assisted laparoscopic procedures and AI-guided endoscopic polyp removal are reducing complication rates, increasing procedure efficiency, and driving higher adoption of advanced endoscopy devices in hospitals, specialty surgical centers, and outpatient clinics worldwide.